People · Operator
Named in public records as an officer, director or promoter · active 2018–2024 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aviceda Therapeutics, Inc. | — | Biotechnology | Series D+ | $173.6M | $707.0M | 2022 |
| Bespoke, Inc. | — | Other Technology | Series A | $14.5M | $4.8M | 2021 |
| Panther Pharmaceuticals, Inc. | — | Biotechnology | Pre-Seed | $200K | $11.0M | 2018 |
Michael Tolentino at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Tolentino on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| David Guyer | 1 | 8 |
| Robert Kniaz | 1 | 5 |
| Patrick Johnson | 1 | 4 |
| Erin Lavelle | 1 | 3 |
| Ross Darwin | 1 | 2 |
| Dmytro Voloshyn | 1 | 2 |
| Mariusz Gralewski | 1 | 2 |
| Kyrylo Bigay | 1 | 2 |
| Christoph Adams | 1 | 1 |
| Tarek Hassan | 1 | 1 |
| Derek Kunimoto | 1 | 1 |
| Jay Woods | 1 | 1 |
| Paul Vukelic | 1 | 1 |
| Derek A. Kunimoto | 1 | 1 |
| Michael A. Tolentino | 1 | 1 |
| Mohamed A. Genead | 1 | 1 |
| George Schaeffer | 1 | 1 |
| Eric Varady | 1 | 1 |
| Antoine Amiel | 1 | 1 |
| Rob Varady | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.